Indraprastha Medical Financial Statements

Indraprastha Medical (INDRAMEDCO) reported revenue of ₹13.79B in FY2025 with net income of ₹1.61B. Total assets stood at ₹8.52B and free cash flow was ₹1.20B.

Indraprastha Medical Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		6.13B	8.91B	11.09B	12.62B	13.79B
Cost of Rev. Cost of Revenue		-1.14B	-1.74B	-1.94B	-2.17B	-2.30B
Gross Profit		5.00B	7.18B	9.15B	10.44B	11.49B
SGA Sales, General & Admin		-4.59B	-6.00B	-7.54B	-8.34B	-8.82B
Op. Income Operating Income		69.47M	824.80M	1.21B	1.70B	2.23B
PBT Profit Before Tax		42.89M	790.70M	1.17B	1.66B	2.16B
Net Income		23.29M	586.20M	861.50M	1.24B	1.61B
Dil. Shares Diluted Shares		91.67M	91.74M	91.65M	91.69M	91.68M
Diluted EPS		0.25	6.39	9.40	13.52	17.56

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Indraprastha Medical's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Indraprastha Medical Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		1.41B	1.57B	2.23B	3.08B	4.31B
Non-curr. assets Total non-current assets		2.91B	3.04B	3.32B	4.15B	4.20B
Total assets		4.32B	4.62B	5.55B	7.23B	8.52B
Curr. liabilities Total current liabilities		1.16B	935.00M	1.30B	1.65B	1.79B
Non-curr. liab. Total non-current liabilities		432.94M	427.70M	460.60M	800.60M	762.30M
Total liabilities		1.59B	1.36B	1.76B	2.45B	2.55B
Total equity		2.73B	3.25B	3.79B	4.78B	5.97B
Total liab. & eq. Total liabilities & equity		4.32B	4.62B	5.55B	7.23B	8.52B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Indraprastha Medical's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Indraprastha Medical Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		42.89M	790.70M	1.17B	1.66B	2.16B
Operating CF Cash flow Operating Activities		278.98M	943.00M	1.44B	2.00B	1.57B
Capex Investments in PPE		-209.63M	-294.80M	-445.80M	-693.90M	-363.30M
Investing CF Cash flow Investing Activities		-201.62M	-741.10M	-1.08B	-1.58B	-1.11B
Dividend Paid		-2.45M	-2.60M	-228.40M	-275.40M	-407.30M
Financing CF Cash flow Financing Activities		-31.47M	-33.70M	-260.40M	-323.80M	-458.80M
Cash (start) Cash at beginning of period		203.32M	249.20M	417.40M	522.60M	616.00M
Cash (end) Cash at end of period		249.21M	417.40M	522.60M	616.00M	614.80M
FCF Free Cash Flow		69.35M	648.20M	998.90M	1.31B	1.20B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Indraprastha Medical's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025